The global nasal drug delivery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth.
A full report of Nasal Drug Delivery Market is available at: https://www.omrglobal.com/industry-reports/nasal-drug-delivery-market
Hence owing to the development and manufacturing of innovative solutions the nasal drug delivery market is augmenting its growth over the forecast period. For instance,
- In May 2022, Birmingham Biotech Ltd. launched BHM Anti-Viral Nasal Spray to help prevent infection from the inhalation of airborne viruses. This spray is easy to use the nasal device with a patented formulation, Norizite, It was developed by the Healthcare Technologies Institute at the University of Birmingham.
- In April 2022, Upper ton Pharma Solutions launched a nasal delivery development platform named as Upper Nose, to access the necessary capabilities for the development of nasal dosage formulations. In this platform, timely develops molecules n both liquid and dry powder nasal formulations.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/nasal-drug-delivery-market
- In December 2021, Orexo had gone into partnership with many companies, to improve adrenaline auto-injectors such as EpiPen and it also developed OX640, a platform for creating particles that combine the drug with carrier materials and it enables nasal delivery. The company has also applied amorphOX drug delivery platform that results in nasal adrenaline candidates.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Dosage Form
o By Containers
o By Therapeutics Application
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- 3M Co., APTARGROUP INC., AstraZeneca, Becton Dickinson and Co., Johnson & Johnson Service Inc., Merck KGaA, Novartis International AG,
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Nasal Drug Delivery Market Report Segment
By Dosage Form
- Gels
- Sprays
- Drops and Liquids
- Other (Powders)
By Containers
- Non-Pressurized Containers
- Pressurized Containers
By Therapeutic Applications
- Rhinitis
- Nasal Congestion
- Asthma
- Others (Vaccination)
By End User
- Hospitals
- Home Health Care
